| Model Number |
3300TFX |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Device Stenosis (4066)
|
| Health Effect - Clinical Codes |
Chest Pain (1776); Fatigue (1849); Dizziness (2194); Insufficient Information (4580)
|
| Date of Event |
12/10/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.
|
| |
|
Event or Problem Description
|
|
It was learned through implant patient registry that a 23mm 3300tfx magna ease valve in the aortic position was explanted and replaced with a 23mm 11500a inspiris resilia aortic valve after an implant duration of 7 years, 28 days.Reason for reintervention is unknown.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.
|
| |
|
Event or Problem Description
|
|
It was learned through implant patient registry and investigation that a 23mm 3300tfx magna ease valve in the aortic position was explanted and replaced with a 23mm 11500a inspiris resilia aortic valve after an implant duration of 7 years, 28 days due to stenosis.The patient presented with chest pain, dizziness, and fatigue.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated sections: b4, b5, b7, g3, g6, h2, h6 (component code, clinical codes, device code).
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated sections: b4, g3, g6, h2, h6 (type of investigation, investigation findings, and investigation conclusions).A device history record (dhr) review is not required because there is no allegation of a malfunction which could be related to a manufacturing non-conformance and/or one was not suspected or confirmed through investigation; no labeling non-conformance/deficiency; no device-related infection; and no evidence of a product failure with regard to design, reliability, or use error (doc-0101337, rev v).Engineering evaluation summary: per doc-0249432, "stenosis is a common manifestation of bioprosthetic valve and valved conduit dysfunction and has many potential root causes, including structural valve deterioration (svd), non-structural valve dysfunction (nsvd), endocarditis and/or thrombosis.Bioprosthetic device stenosis is typically related to patient and/or procedural factors and is not typically an indication of a device malfunction related to a manufacturing deficiency." there is no evidence to suggest a manufacturing defect caused or contributed to the reported event.The most likely root cause is patient factors, including hyperlipidemia.
|
| |
|
Search Alerts/Recalls
|